Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Methyl N-(((3r)-3-hydroxy-4-((3-methoxy-3-oxopropyl)amino)-2,2-dimethyl-4-oxobutoxy)(phenoxy)phosphoryl)-l-alaninate
2. Re-024
1. 1858268-66-2
2. Re-024
3. Fosmetpantotenate (usan)
4. Fosmetpantotenate [usan]
5. Methyl 3-((2r)-2-hydroxy-4-(((((s)-1-methoxy-1-oxopropan-2-yl)amino)(phenoxy)phosphoryl)oxy)-3,3-dimethylbutanamido)propanoate
6. Unii-va101m0k2f
7. Va101m0k2f
8. Chembl3989938
9. Schembl15346116
10. Hy-109033
11. Cs-0030654
12. D10934
13. 5-oxa-3,10-diaza-4-phosphatridecanedioic Acid, 8-hydroxy-2,7,7-trimethyl-9-oxo-4-phenoxy-, 1,13-dimethyl Ester, 4-oxide, (2s,8r)-
14. Dimethyl 8-hydroxy-2,7,7-trimethyl-4,9-dioxo-4-phenoxy-5-oxa-3,10-diaza-4-lambda5-phosphatridecanedioate, Mixture Of (2s,4r,8r) And (2s,4s,8r) Epimers
15. Methyl (2s)-2-[[[(3r)-3-hydroxy-4-[(3-methoxy-3-oxopropyl)amino]-2,2-dimethyl-4-oxobutoxy]-phenoxyphosphoryl]amino]propanoate
16. Methyl 3-((2r)-2-hydroxy-4-(((((s)-1-methoxy-1-oxopropan-2-yl)amino)(phenoxy) Phosphoryl)oxy)-3,3-dimethylbutanamido)propanoate
| Molecular Weight | 474.4 g/mol |
|---|---|
| Molecular Formula | C20H31N2O9P |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 15 |
| Exact Mass | 474.17671757 g/mol |
| Monoisotopic Mass | 474.17671757 g/mol |
| Topological Polar Surface Area | 150 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 680 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of Pantothenate Kinase Associated Neurodegeneration
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
47
PharmaCompass offers a list of Fosmetpantotenate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fosmetpantotenate manufacturer or Fosmetpantotenate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fosmetpantotenate manufacturer or Fosmetpantotenate supplier.
PharmaCompass also assists you with knowing the Fosmetpantotenate API Price utilized in the formulation of products. Fosmetpantotenate API Price is not always fixed or binding as the Fosmetpantotenate Price is obtained through a variety of data sources. The Fosmetpantotenate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fosmetpantotenate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fosmetpantotenate, including repackagers and relabelers. The FDA regulates Fosmetpantotenate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fosmetpantotenate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fosmetpantotenate supplier is an individual or a company that provides Fosmetpantotenate active pharmaceutical ingredient (API) or Fosmetpantotenate finished formulations upon request. The Fosmetpantotenate suppliers may include Fosmetpantotenate API manufacturers, exporters, distributors and traders.
Fosmetpantotenate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fosmetpantotenate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fosmetpantotenate GMP manufacturer or Fosmetpantotenate GMP API supplier for your needs.
A Fosmetpantotenate CoA (Certificate of Analysis) is a formal document that attests to Fosmetpantotenate's compliance with Fosmetpantotenate specifications and serves as a tool for batch-level quality control.
Fosmetpantotenate CoA mostly includes findings from lab analyses of a specific batch. For each Fosmetpantotenate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fosmetpantotenate may be tested according to a variety of international standards, such as European Pharmacopoeia (Fosmetpantotenate EP), Fosmetpantotenate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fosmetpantotenate USP).
